Posterolateral inter-transverse lumbar fusion in a mouse model
© Bobyn et al.; licensee BioMed Central Ltd. 2013
Received: 4 October 2011
Accepted: 10 January 2013
Published: 23 January 2013
Spinal fusion is a common orthopaedic procedure that has been previously modeled using canine, lapine, and rodent subjects. Despite the increasing availability of genetically modified mouse strains, murine models have only been infrequently described.
To present an efficient and minimally traumatic procedure for achieving spinal fusion in a mouse model and determine the optimal rhBMP-2 dose to achieve sufficient fusion mass.
MicroCT reconstructions of the unfused mouse spine and human spine were compared to design a surgical approach. In phase 1, posterolateral lumbar spine fusion in the mouse was evaluated using 18 animals allocated to three experimental groups. Group 1 received decortication only (n = 3), Group 2 received 10 μg rhBMP-2 in a collagen sponge bilaterally (n = 6), and Group 3 received 10 μg rhBMP-2 + decortication (n = 9). The surgical technique was assessed for intra-operative safety, efficacy, access and reproducibility. Spines were harvested for analysis at 3 weeks (Groups 1, 2) and 1, 2, and 3 weeks (Group 3). In phase 2, a dose response study was carried out in an additional 18 animals with C57BL6 mice receiving sponges containing 0, 0.5, 1, 2.5, 5 μg of rhBMP-2 per sponge bilaterally.
The operative procedure via midline access was rapid and reproducible, and fusion of the murine articular processes was found to be analogous to the human procedure. Unlike reports from other species, decortication alone (Group 1) yielded no new bone formation. Addition of rhBMP-2 (Groups 2 and 3) yielded a significant bone mass that bridged the L4-L6 vertebrae. The subsequent dose response experiment revealed that 0.5 μg rhBMP-2 per sponge was sufficient to create a fusion mass.
We describe a new approach for mouse lumbar spine fusion that is safe, efficient, and highly reproducible. The technique we employed is analogous to the human midline procedure and may be highly suitable for genetically modified mouse models.
Spinal fusion surgery has been performed since the pioneering work of Hibbs , Albee  and DeQuervain in the early 20th century. When successful the procedure has significantly reduced the morbidity associated with spinal deformity and, controversially, discomfort. Historically, the procedure has suffered from high rates of non-union. It has been estimated that 5-30% of spinal fusion procedures result in pseudarthrosis , the causes of which are certainly multifactorial.
Animal surgical models have been utilized extensively to improve surgical technique and gain insight into the mechanisms of spinal fusion failure. Larger animals such as canine [4–8] and ovine subjects [9, 10] have traditionally been employed due to their close approximation of the size and anatomy of human patients. Rat and rabbit studies [11–21] typically represent the lower limit with respect to size that spine fusion procedures have been attempted. Mouse models have rarely been studied, likely owing to the technical difficulty associated with surgical access and technique demanded by their small size. Until recently, spinal fusion attempts in mice have been limited to percutaneous injection of BMP solution and mesenchymal stem cells into the paraspinal musculature [22, 23], thereby obviating the need to surgically expose and manipulate the vertebral structures.
Advancements in transgenic mice have encouraged the use of surgical models that explore the impact of genetics on repair and regeneration. In 2007, Rao et al. () proposed a technique for performing posterolateral lumbar spinal fusion in mice, using a modified version of the paraspinal approach described by Wiltse . Fusion was induced via autogenous bone graft from donor mouse of same strain or rhBMP-2 delivered in a collagen sponge. Radiographic assessment demonstrated that a dense fusion mass was formed in 62% of fusion sites, although no specific breakdown was given for the bone graft and rhBMP-2 groups. This model also featured a prolonged operating time of 60 min.
In this study we have utilized a surgical approach involving a single midline incision through the thoracolumbar fascia that more closely approximates the current human midline surgical technique. Such an approach aimed to minimize tissue trauma as well as increase visibility and access to the articular processes. One other aim of this modified procedure was to minimize the operative time and maximize the experimental reproducibility between subjects and the rate of spine fusion.
Anatomical Analysis by MicroCT
The spines of 5 C57BL6 mice, aged between 8 and 10 weeks, were harvested and analyzed via microCT using a SkyScan 1174 compact microCT scanner (SkyScan, Kontich, Belgium). Samples were scanned in 70% ethanol at 21.3 um magnification, 0.5 mm aluminium filter, 50 kV X-ray tube voltage and 800 μA tube electric current. The images were reconstructed using NRecon, version 184.108.40.206 (SkyScan). A global threshold was used representing bone tissue. Representative three-dimensional fractures were reconstructed with sagittal slices using CTVol Realistic Visualisation software version 220.127.116.11 (SkyScan). The structure of the lumbar spine was documented and compared with the relevant human anatomy. Subsequently, 5 additional mice were culled and the lumbar spine was dissected. The relationships of the soft tissue to the bone were observed and documented with a view to establishing a clear and efficient surgical access to the lumbar vertebrae which would allow secure positioning of a collagen sponge for the delivery of osteoblast stimulating factors.
18 C57BL6 mice (male and female aged 8–10 weeks) received posterolateral lumbar spine fusion surgery. Surgery was performed by a two surgeons in a single sitting with anesthetic support from an experienced animal technician. Group 1 received decortication only (n = 3), Group 2 received 10μg rhBMP-2 in a collagen sponge bilaterally (n = 6), and Group 3 received 10 μg rhBMP-2 + decortication (n = 9).
Mice were anaesthetized with ketamine (35 mg/kg)/xylazine (5 mg/kg) solution administered intraperitoneally. Hair overlying the operative site was shaved with an electric razor once anaesthetized and the area prepped with iodine. Animals were positioned prone with folded gauze beneath the abdomen, increasing the excursion of the lumbar spine to facilitate access to and visibility of the surgical field. The head was covered with saline soaked gauze to protect the ears from overheating under operating lights. rhBMP-2 marketed under the brand name Infuse® (Medronic Australasia) was used in this study. Prior to surgery, the collagen sponge that was supplied with the vial of BMP for human use was cut into 2 mm × 7 mm sections. A solution of saline and BMP was made allowing the accurate pipetting of 10 μg of BMP onto each sponge intra-operatively.
Two collagen sponges, impregnated with either saline or an rhBMP-2/saline solution (containing 10 μg of BMP per sponge), were placed bilaterally in the potential space which has been created (Figure 1E). The fascia was apposed and closed with a single line of continuous sutures using 6.0 Vicryl, The skin was subsequently closed in the same fashion. Mice were placed on a heat pad following surgery and monitored for recovery. Antibiotics were administered in the drinking water for 24 hours postoperatively.
Once the safety and efficacy of the surgical model had been demonstrated, it was applied to a small study involving 15 C57BL6 mice to determine the optimal dose of rhBMP-2 required to establish fusion of the spine. Mice were divided into dose groups of 0, 0.5, 1, 2.5, and 5 μg of rhBMP-2 per sponge bilaterally and culled at 3 weeks. Spines were harvested and fixed in 4% paraformaldehyde for 24 hours and then analyzed by X-ray and microCT were used to visualize new bone formation.
Following harvesting and fixation in 4% paraformaldehyde, microCT data was obtained via SkyScan 1174 compact microCT scanner (SkyScan, Kontich, Belgium). Samples were scanned in 70% ethanol at 21.3 um magnification, 0.5 mm aluminum filter, 50 kV X-ray tube voltage and 800 μA tube electric current. The images were reconstructed using NRecon, version 18.104.22.168 (SkyScan). A global threshold was used representing bone tissue. Representative three-dimensional fractures were reconstructed with sagittal slices using CTVol Realistic Visualization software version 22.214.171.124 (SkyScan). For the purposes of bone volume and density calculation, the bone of the fusion mass was isolated from native bone by means of manually drawn regions of interest (ROI).
Harvested vertebrae and surrounding musculature were fixed in 4% paraformaldehyde for 24 hours at 4°C on a shaker were and then stored in 70% ethanol until ready for decalcification. Samples were decalcified in 0.34M EDTA (pH 8.0) solution at 4°C on a shaker for 30 days with solution changes every 2–3 days. Samples were next embedded in paraffin and sectioned transversely through the center of the fusion mass at a thickness of 5 microns. Mounted sections were stained via Picro Sirius Red/Alcian Blue to differentiate bone and cartilage.
The significance of the medians and distribution of bone volume data as a function of increasing dose was first analyzed via stringent non-parametric statistics (Kruskal-Wallis independent sample test; SPSS Statistics v18). Using an assumption of normally distributed data, an ANOVA with post-hoc Bonferroni test was then performed to compare individual groups. The limit for statistical significance was set at 0.05. Correlation was tested using a Pearson product–moment correlation test (Excel 2010) to generate the R-value. Significance was tested by calculating the t-value using the formula t = (r*(n-2)^0.5)/((1-r^2)^0.5) and significance calculated using the tdist function.
All animal experimentation was performed with ethics approval granted by the Westmead Hospital Animal Ethics Committee under protocol 5056.
Anatomical examination of the unfused mouse spine
Surgical timing and morbidity
There was no intra- or post- operative morbidity or mortality in either the fusion outcome study or the rhBMP-2 dose response study. Animals were monitored for neurological impairment (particularly of the hind limbs), wound infection, weight loss and distressed behavior. Operative time, in the hands of an experienced surgeon, was approximately 15 minutes skin to skin. We believe that the brief operating, and hence anesthetic time as well as the minimized trauma contributed significantly to the observed safety of the procedure.
rhBMP-2 dose response study
Historically, larger animals have been used to model spine fusion surgery due to their proximity in size and anatomy to humans. Recent advancements in transgenic mice have generated an experimental niche for the use of murine surgical models. Knockout and transgenic mice offer a unique opportunity for insight into the genetic and cellular mechanisms underlying bone repair . Idiopathic scoliosis (IS) is the most common cause of spinal deformity in children, but the etiology of the disease has remained elusive. Recent research has found a strong association between mutations of the CHD7 gene and the development of IS . The potential exists to replicate CHD7-mutation dependent IS in transgenic mice and to investigate intervention therapies in an accurate murine model. Similar advantages are offered to the modeling of scoliosis in neurofibromatosis type 1 (NF1) patients. NF1 is the most common single gene disorder and at least 23% of patients diagnosed with NF1 will show signs of scoliosis in childhood [28, 29]. A mouse model for modeling human NF1 deficiency is currently available, and while it does not spontaneously develop scoliosis it shows impaired long bone healing and response to rhBMP treatment [30, 31]. There are several additional advantages using the mouse as an experimental organism. The small size of the mouse, though technically challenging, facilitates relatively quick operations and allows for low intra-operative morbidity and mortality. Furthermore, when combined with its short generation time and inexpensive housing costs, makes it a valuable high throughput model.
A major drawback to using the mouse to replicate human surgery lies in the anatomical differences between the two species. With respect to the lumbar spine, our investigation into the murine anatomy yielded several distinct morphological differences between the mouse and the human lumbar vertebrae which have been previously overlooked, particularly the position and orientation of the transverse processes. However, the structural similarities of the mouse articular processes and the human transverse processes may be exploited to yield a procedure that is functionally analogous to that which is performed in humans.
Previous mouse and rat models of posterolateral spine fusion have adopted a modification of the Wiltse technique which utilizes a paraspinal approach to the transverse processes [19, 24, 25]. Given the anatomical differences between rodents and humans we don’t believe that this is an optimal approach. Furthermore, the Wiltse technique uses twice as many incisions as a midline approach and is not currently in popular practice. The result is a procedure that does not mimic contemporary technique or relevant anatomy and leads to longer operating times with a consequent risk of increased morbidity and mortality. The surgical approach used in this study minimizes the number of incisions, tissue trauma and ultimately the total operative time. In mice who only received articular process decortication as intervention, no bone formation was observed. Additionally, little difference was observed by the addition of decortication to the mice receiving rhBMP-2 suggesting intrinsic intraspecies differences with larger animals. Canines have been reported to readily fuse following decortication alone , and decortication is also a common clinical practice in spine fusion surgery.
Our initial study used an rhBMP-2 dose of 10μg per sponge, based upon scaling down doses commonly used to create a large bone mass in rabbits [33, 34]. This yielded a very large amount of bone formation which is equal to or greater in volume than the spine itself. Such a large mass of bone suggests that the mouse spine is particularly sensitive to the osteogenic effects of rhBMP-2 and that a functional and stabilizing fusion mass could be achieved with a lower dose. We propose that the overwhelming response to the 10 μg dose may be obscuring the influence of additional variables, such as decortications of the articular processes. A follow-up study was performed to determine the minimum dose of BMP-2 required for fusion. A dose response relationship between rhBMP-2 and the volume of the 3 week fusion mass was observed. It was found that a dose of 0.5 μg, equivalent to 5% of the original dose, was sufficient to achieve successful fusion. The resulting fusion mass was significantly smaller than that achieved using 5 μg or 10 μg rhBMP-2. This smaller fusion mass may be more sensitive to the effects of intervention.
In summary, we have demonstrated that a midline approach to posterolateral interarticular process spine fusion in a mouse model is safe, efficient, and yields consistent and reproducible results. A BMP-2 dose of 0.5 μg per sponge was sufficient to achieve fusion of adjacent vertebrae. By exploiting anatomical similarities between the species, the technique closely mirrors that which is used in humans. The development of a surgical protocol in mice that is functionally analogous to the procedure in human patients is advantageous. This model permits the rapid observation of a large number of subjects over a relatively short period of time and allows valid extrapolation of reproducible data and results, thereby fulfilling the criteria for the ideal animal model as proposed by Schimandle and Boden .
This work was supported by funding from Australian National Health & Medical Research Council Project Grants (1003478, 1003480).
- Hibbs RA: A further consideration of an operation for pott’s disease of the spine: with report of cases from the service of the New York orthopaedic hospital. Ann Surg. 1912, 55 (5): 682-688. 10.1097/00000658-191205000-00003.PubMed CentralView ArticlePubMedGoogle Scholar
- Albee FH: The classic. Transplantation of a portion of the tibia into the spine for Pott’s disease. A preliminary report. Jama, 57: 885, 1911. Clin Orthop Relat Res. 1972, 87: 5-8.View ArticleGoogle Scholar
- DePalma AF, Rothman RH: The nature of pseudarthrosis. Clin Orthop Relat Res. 1968, 59: 113-118.View ArticlePubMedGoogle Scholar
- Delecrin J: Influence of local environment on incorporation of ceramic for lumbar fusion. Comparison of laminar and intertransverse sites in a canine model. Spine (Phila Pa 1976). 1997, 22 (15): 1683-1689. 10.1097/00007632-199708010-00001.View ArticleGoogle Scholar
- Emery SE: The biological and biomechanical effects of irradiation on anterior spinal bone grafts in a canine model. J Bone Joint Surg Am. 1994, 76 (4): 540-548.PubMedGoogle Scholar
- Hurley LA: The role of soft tissues in osteogenesis. An experimental study of canine spine fusions. J Bone Joint Surg Am. 1959, 41-A: 1243-1254.PubMedGoogle Scholar
- McAFEE PC: The effect of spinal implant rigidity on vertebral bone density a canine mode. Spine. 1991, 16 (6S): S190-S197.View ArticlePubMedGoogle Scholar
- Sandhu HS: Evaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model. Spine (Phila Pa 1976). 1995, 20 (24): 2669-2682. 10.1097/00007632-199512150-00008.View ArticleGoogle Scholar
- Drespe IH: Animal models for spinal fusion. Spine J. 2005, 5 (6 Suppl): 209S-216S.View ArticlePubMedGoogle Scholar
- Nagel DA: A paradigm of delayed union and nonunion in the lumbosacral joint - a study of motion and bone-grafting of the lumbosacral spine in sheep. Spine. 1991, 16 (5): 553-559. 10.1097/00007632-199105000-00012.View ArticlePubMedGoogle Scholar
- Boden SD: The biology of posterolateral lumbar spinal fusion. Orthop Clin N Am. 1998, 29 (4): 603-10.1016/S0030-5898(05)70034-1.View ArticleGoogle Scholar
- Bouchard JA: Effects of irradiation on posterior spinal fusions a rabbit model. Spine. 1994, 19 (16): 1836-1841. 10.1097/00007632-199408150-00008.View ArticlePubMedGoogle Scholar
- Daftari TK: Nicotine on the revascularization of bone graft: an experimental study in rabbits. Spine. 1994, 19 (8): 904-911. 10.1097/00007632-199404150-00007.View ArticlePubMedGoogle Scholar
- Feiertag MA: A rabbit model for nonunion of lumbar intertransverse process spine arthrodesis. Spine (Phila Pa 1976). 1996, 21 (1): 27-31. 10.1097/00007632-199601010-00006.View ArticleGoogle Scholar
- Palumbo M: Posterolateral intertransverse lumbar arthrodesis in the New Zealand White rabbit model: I. Surgical anatomy. Spine J. 2004, 4 (3): 287-292. 10.1016/j.spinee.2003.11.004.View ArticlePubMedGoogle Scholar
- Valdes M: Posterolateral intertransverse lumbar arthrodesis in the New Zealand White rabbit model: II. Operative technique. Spine J. 2004, 4 (3): 293-299. 10.1016/j.spinee.2003.08.022.View ArticlePubMedGoogle Scholar
- Wing KJ: Stopping nicotine exposure before surgery: the effect on spinal fusion in a rabbit model. Spine. 2000, 25 (1): 30-10.1097/00007632-200001010-00007.View ArticlePubMedGoogle Scholar
- Ahrengart L: Periarticular heterotopic ossification after total hip arthroplasty: risk factors and consequences. Clin Orthop Relat Res. 1991, 263: 49-58.PubMedGoogle Scholar
- Salamon ML: The effects of BMP-7 in a rat posterolateral intertransverse process fusion model. J Spinal Disord Tech. 2003, 16 (1): 90-95. 10.1097/00024720-200302000-00014.View ArticlePubMedGoogle Scholar
- Schimandle JH, Boden SD: Spine update. The use of animal models to study spinal fusion. Spine (Phila Pa 1976). 1994, 19 (17): 1998-2006. 10.1097/00007632-199409000-00023.View ArticleGoogle Scholar
- Wang JC: Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. J Bone Joint Surg Am. 2003, 85-A (5): 905-911.PubMedGoogle Scholar
- Hasharoni A: Murine spinal fusion induced by engineered mesenchymal stem cells that conditionally express bone morphogenetic protein—2. J Neurosurg Spine. 2005, 3 (1): 47-52. 10.3171/spi.2005.3.1.0047.View ArticlePubMedGoogle Scholar
- Alden TD: Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy. J Neurosurg Spine. 1999, 90 (1): 109-114.View ArticleGoogle Scholar
- Rao RD, Bagaria VB, Cooley BC: Posterolateral intertransverse lumbar fusion in a mouse model: surgical anatomy and operative technique. Spine J. 2007, 7 (1): 61-67. 10.1016/j.spinee.2006.03.004.View ArticlePubMedGoogle Scholar
- Wiltse LL: The paraspinal sacrospinalis-splitting approach to the lumbar spine. J Bone Joint Surg Am. 1968, 50 (5): 919-926.PubMedGoogle Scholar
- Schindeler A, Liu R, Little DG: The contribution of different cell lineages to bone repair: exploring a role for muscle stem cells. Differentiation. 2009, 77 (1): 12-18. 10.1016/j.diff.2008.09.007.View ArticlePubMedGoogle Scholar
- Gao X: CHD7 Gene polymorphisms are associated with susceptibility to idiopathic scoliosis. Am J Hum Genet. 2007, 80 (5): 957-965. 10.1086/513571.PubMed CentralView ArticlePubMedGoogle Scholar
- Tonsgard JH: Clinical manifestations and management of neurofibromatosis type 1. Semin Pediatr Neurol. 2006, 13 (1): 2-7. 10.1016/j.spen.2006.01.005.View ArticlePubMedGoogle Scholar
- Young H, Hyman S, North K: Review article: neurofibromatosis 1: clinical review and exceptions to the rules. J Child Neurol. 2002, 17 (8): 613-621. 10.1177/088307380201700812.View ArticlePubMedGoogle Scholar
- Hinrichs S: A transgenic mouse model for human neurofibromatosis. Science. 1987, 237 (4820): 1340-1343. 10.1126/science.2888191.View ArticlePubMedGoogle Scholar
- Schindeler A: Distal tibial fracture repair in a neurofibromatosis type 1-deficient mouse treated with recombinant bone morphogenetic protein and a bisphosphonate. J Bone Joint Surg Br Vol. 2011, 93-B (8): 1134-1139. 10.1302/0301-620X.93B8.25940.View ArticleGoogle Scholar
- Callewart CC, Kanim LE, Dawson EG: Evaluation of the canine spinal fusion method. 1993, San Dieg, CA: North American Spine Society Annual Meeting, OctoberGoogle Scholar
- Minamide A: Evaluation of carriers of bone morphogenetic protein for spinal fusion. Spine (Phila Pa 1976). 2001, 26 (8): 933-939. 10.1097/00007632-200104150-00017.View ArticleGoogle Scholar
- Itoh H: Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2. Spine. 1999, 24 (14): 1402-10.1097/00007632-199907150-00003.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.